SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-098276
Filing Date
2021-03-29
Accepted
2021-03-29 16:09:45
Documents
14
Period of Report
2021-03-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d28637d8k.htm   iXBRL 8-K 28325
2 EX-99.1 d28637dex991.htm EX-99.1 33871
6 GRAPHIC g28637g0329114153849.jpg GRAPHIC 6239
  Complete submission text file 0001193125-21-098276.txt   206613

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA wve-20210329.xsd EX-101.SCH 3091
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20210329_lab.xml EX-101.LAB 18071
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20210329_pre.xml EX-101.PRE 11399
7 EXTRACTED XBRL INSTANCE DOCUMENT d28637d8k_htm.xml XML 3439
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 21781791
SIC: 2834 Pharmaceutical Preparations